Satoshi Okayama
About
In The Last Decade
Satoshi Okayama
90 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Cardiology and Cardiovascular Medicine 875
- Radiology, Nuclear Medicine and Imaging 520
- Surgery 487
- Pulmonary and Respiratory Medicine 275
- Molecular Biology 230
Countries citing papers authored by Satoshi Okayama
This map shows the geographic impact of Satoshi Okayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Okayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Okayama more than expected).
Fields of papers citing papers by Satoshi Okayama
This network shows the impact of papers produced by Satoshi Okayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Okayama. The network helps show where Satoshi Okayama may publish in the future.
Co-authorship network of co-authors of Satoshi Okayama
This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Okayama. A scholar is included among the top collaborators of Satoshi Okayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Okayama. Satoshi Okayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 29 | |
| 3 | 24 | |
| 4 | 5 | |
| 5 | 穏和減少した左室駆出率(EF)のHFに対して保持されたEFの心不全(HF)からのHFへの遅延性移行のためのカットオフ値としての55%左室駆出率(EF) | 14 |
| 6 | 3 | |
| 7 | 15 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 32 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 4 | |
| 14 | Plasma level of soluble Fms-like tyrosine kinase 1 (sFIt-1) as a predictive marker of acute severe heart failure in patients with acute myocardial infarction | 1 |
| 15 | 26 | |
| 16 | 69 | |
| 17 | 41 | |
| 18 | 74 | |
| 19 | 13 | |
| 20 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.